
    
      The purpose of this study is to assess the safety, tolerability, pharmacokinetics and
      pharmacodynamics in young and elderly healthy volunteers of HTL9936, a selective M1 receptor
      agonist intended for the treatment of cognitive disorders. This study is a single ascending
      dose study.
    
  